CoMorPD

The LTC CoMorPD emerges the consolidation of a long-lasting and fruitful collaboration between two laboratories with an extensive scientific career in the research field of Parkinson’s disease (PD).
This LTC encompasses a scientific but also an academic objective. From the scientific point of view, we will study the non-motor complications in PD, focusing on the interaction between limbic nuclei and basal ganglia at the aetiology and therapeutic levels.
The LTC CoMorPD aims at (1) identifying the causes of the disease, (2) evaluating the impact on the neuronal circuit communication and (3) providing proof of concept for improving the therapeutics.
This approach will gather the expertise from both laboratories, which represents a perfect fit due to their scientific and methodological complementarities. In addition to the scientific question, this LTC will also contribute to the generation of a dynamic network between both universities to favour the mobility of students and researchers and the participation in academic activities as teaching.
The LTC CoMorPD has also the ambition to foster collaborations with clinicians and industrial partners to identify biomarkers and propose early diagnostic of PD.